Welcome to the e-CCO Library!

P297: The change of bone mineral density in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Moon*1, S. J. Park1, M. I. Park1, S. E. Kim1, J. H. Kim1, K. Jung1

Created: Friday, 22 February 2019, 9:41 AM
P297: The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn's Disease Patients – A Construct Validation Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Zittan, E.(1,2,3)*;Levy, M.(1,2);Saban , L.(1); Vered, S.(4); Steinhart, A.H.(5); Milgrom, R.(5); Gralnek, I.M.(1,2); Silverberg, M.S.(5); Zelber-Sagi, S.(3);
Created: Friday, 14 July 2023, 11:05 AM
P297: Treatment of patients with complex perianal Crohn's disease with darvadstrocel: a single-institution real life experience.
Year: 2022
Source: ECCO'22
Authors: BorruelPhD, N.(1);Martí, M.(2);Armario, D.(3);Ibarz, A.(1);Robles, V.(1);Herrera, C.(1);Mayorga, L.(1);Pérez, Z.(1);Alonso, C.(4);Elena, C.(1);Planes, M.(3);Oller, E.(1);Espín, E.(5);Casellas, F.(1);
Created: Friday, 11 February 2022, 3:52 PM
P297: Ulcerative colitis and proximal extension of the disease: a sub-group with worse prognosis?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Sousa*, D. Martins, J. Pinho, R. Araújo, E. Cancela, A. Castanheira, P. Ministro, A. Silva

Created: Friday, 22 February 2019, 9:49 AM
P298 Patient-reported outcomes: the ICHOM standard set for IBD in real-life practice helps quantify deficits in current care
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Wong, R. Kantschuster, L. Matini, D. Simadibrata, M. Lepetyukh, J. Wilson, O. Brain, R. Palmer, T. Ambrose, J. Satsangi, S. Travis, A.J. Walsh

Created: Thursday, 30 January 2020, 10:12 AM
P298: Budesonide MMX versus Prednisolone for Ulcerative Colitis: Comparative outcomes from a British retrospective multi-centre study
Year: 2021
Source: ECCO'21 Virtual
Authors: Rosiou , K.(1);Ong Ming San , E.(1);Kumar , A.(2);Esquivel , K.(2);Almas , S.(2);Stokes , D.(2);Ng , T.(3);Jayasooriya , N.(3);Ranasinghe , I.(3);Pollok , R.(3);Brookes , M.(2);Selinger , C.P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P298: Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pittet V.*1, Maillard M.H.2, Rogler G.3, Michetti P.4

Created: Wednesday, 20 February 2019, 10:36 AM
P298: Comparison of the familial and sporadic cases of inflammatory bowel diseases in long-term follow-up regarding step-up treatment, clinical, and biochemical parameters
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Bozcan*, I. Hatemi, Y. Erzin, G. Ayan, A. Satman, T. Gundogdu, K. Atay, N. Demir, A.F. Celik

Created: Friday, 22 February 2019, 9:49 AM
P298: Crohn’s disease or intestinal tuberculosis: The unsolved enigma
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Elleuch, W. Dahmani*, A. Ben Slama, A. Hammami, H. Jaziri, A. Brahem, M. Ksiaa, A. Jmaa

Created: Thursday, 21 February 2019, 9:14 AM
P298: Pregnancy in Crohn's and Colitis - Observations, Levels and Outcomes Extension (PICCOLO-X) Study: Biological therapy reduces faecal calprotectin and the need for corticosteroids in pregnant women with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Prentice, R.(1);Wright, E.(2);Flanagan, E.(2);Goldberg, R.(1);Prideaux, I.(1);Ross, A.(2);Burns, M.(1);Bell, S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P298: Risk factors for the progression of non-alcoholic fatty liver disease in people with inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Walker, C.(1)*;Dempsey, M.(1);Connaughton, R.(1);Carroll, A.(1);Breslin, N.(1);McNamara, D.(1);O'Donnell, S.(1);Ryan, B.(1);O'Connor, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P298: Wall thickness ratio, a new magnetic resonance parameter, predicts the outcome of biological therapy in patients with ileal and ileocolonic Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Balestrieri*1, M. Ribolsi1, A. Tullio1, E. Solida1, A. Giordano1, M. Cicala1

Created: Friday, 22 February 2019, 9:41 AM
P299 A prospective randomised trial comparing dye-based chromoendoscopy with electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. González-Bernardo1,2, S. Vivas3, R. de Francisco1,4, I. Pérez-Martínez1,4, A. Castaño-García1,4, V. Jiménez-Beltrán1, P. Flórez-Díez1, S. Martínez-González4, V. Rolle5, P. Suárez5, A. Suárez1,4, S. Riestra Menéndez1,4

Created: Thursday, 30 January 2020, 10:12 AM
P299: A novel ileocolonic Crohn’s staging tool: the development and validation of an evidence-based, end-user informed radiological decision-aid
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. S. Morar*1,2, K. A. Wasmann3, A. C. T. Fareleira4, K. Sahnan1,2, S. O. Adegbola1,2, E. Mainta1, R. Ilangovan1, S. Arora2, N. Sevdalis5, K. Koysombat1, A. Hart1,2, D. Burling1, C. Edwards6, J. Warusavitarne1,2, A. Gupta1, W. A. Bemelman3, O. Faiz1,2

Created: Friday, 22 February 2019, 9:41 AM
P299: Disability in newly diagnosed patients with Crohn´s Disease: initial results from the prospective CROCO (Crohn´s Disease Cohort) Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tinoco da Silva TorresMD- PhD, J.(1,2)*;Ellul, P.(3);Vieujean, S.(4);Ordas, I.(5);Burisch, J.(6);Mocanu, I.(7);Duricova, D.(8);Rodríguez-Lago, I.(9);Buisson, A.(10);Goldis, A.(11);Hernandez, V.(12);Arebi, N.(13);Kaimakliotis, I.(14);Nachury, M.(15);Fumery, M.(16);Allocca, M.(17);Pedersen, N.(18);Barberio, B.(19);Shaji, S.(20);Guedes, A.(21);Ribeiro, R.(21);Ungaro, R.(22);Lambert, J.(23);Colombel, J.F.(22);
Created: Friday, 14 July 2023, 11:05 AM
P299: Identification of a prognostic biomarker able to predict ulcerative colitis patients that will not respond to standard therapy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pereira M.1, Carvalho S.1, Azevedo L.2, Albergaria A.1, Lima J.1, Reis C.3, Pedroto I.4, Maia L.4, Marcos-Pinto R.4, Lago P.4, Pinho S.S.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P299: Is quality of life different between Crohn’s disease patients submitted to early surgery or immunosuppression?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Barosa*, M. Patita, G. Nunes, C. Carreira, C. Cruz, C. Boal, A. I. Vieira, J. Freitas

Created: Friday, 22 February 2019, 9:49 AM
P299: Loss-of-response to anti-tumour necrosis factor-α critically depends on treatment duration in patients with Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Schultheiss, J.(1);Mahmoud, R.(1);Louwers, J.(1);van der Kaaij, M.(1);van Hellemondt, B.(1);van Boeckel, P.(2);Mahmmod, N.(2);Jharap, B.(3);Fidder, H.(1);Oldenburg, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P299: Prediction model for steroid-free clinical remission with vedolizumab at week 22 in patients with Ulcerative Colitis: Machine learning using clinical data at baseline
Year: 2022
Source: ECCO'22
Authors: Miyoshi, J.(1);Maeda, T.(2);Matsuoka, K.(3);Saito, D.(1);Morikubo, H.(1);Matsuura, M.(1);Tamura, S.(2);Hisamatsu, T.(1);
Created: Friday, 11 February 2022, 3:52 PM
P299: Relation of body mass index and health outcomes in elderly patients with inflammatory bowel disease (IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Slagboom, V. Asscher*, L. Meijer, S. Waars, A. Van der Meulen- de Jong, J. Maljaars

Created: Thursday, 21 February 2019, 9:14 AM